AnalystsJames CondulisJames Condulis's Stock Forecasts
AnalystsJames Condulis
Sectors:
Industries:
Analyst Ranking
Bottom 13%
#4846 out of 5549 analysts
Average Return
-3.86%
Win Rate
31%5 out of 16
Risk vs Reward
Poor
Good
James Condulis's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Amylyx Pharmaceuticals IncAMLX | +103.26% | $14.11 | $28.68 | 2026-03-03 - 2026-10-29 | Strong Buy |
Cytokinetics IncCYTK | +43.89% | $49.62 | $71.40 | 2025-09-02 - 2026-09-01 | Strong Buy |
Newamsterdam Pharma Co NvNAMS | +39.10% | $21.84 | $30.38 | 2025-06-10 - 2026-06-09 | Strong Buy |
Cytokinetics IncCYTK | +34.64% | $46.82 | $63.04 | 2025-01-22 - 2026-01-21 | Strong Buy |
Mirum Pharmaceuticals IncMIRM | +4.85% | $82.39 | $86.39 | 2026-10-15 - 2026-10-29 | Strong Buy |
James Condulis Analyst Color
Get additional color on James Condulis's coverage of popular stocks
James Condulis's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Mirum Pharmaceuticals IncMIRM | 2 | Strong Buy | $156.00 | +80.58% | Maintains | 15 days ago |
Achieve Life Sciences IncACHV | 1 | Strong Buy | $18.00 | +150.35% | Initiates Coverage On | a month ago |
Braveheart Bio IncBRVE | 1 | Strong Buy | $45.00 | +112.36% | Initiates Coverage On | 2 months ago |
Arrowhead Pharmaceuticals IncARWR | 1 | Strong Buy | $98.00 | +62.01% | Initiates Coverage On | 4 months ago |
Fulcrum Therapeutics IncFULC | 1 | Hold | $3.00 | -20.42% | Downgrades | 5 months ago |
Cytokinetics IncCYTK | 3 | Strong Buy | $108.00 | +70.59% | Maintains | 6 months ago |
Tectonic Therapeutic IncTECX | 1 | Strong Buy | $75.00 | +265.85% | Initiates Coverage On | 7 months ago |
Amylyx Pharmaceuticals IncAMLX | 1 | Strong Buy | $21.00 | -26.78% | Initiates Coverage On | 8 months ago |
Aardvark Therapeutics IncAARD | 2 | Hold | $6.00 | +316.67% | Downgrades | 8 months ago |
Newamsterdam Pharma Co NvNAMS | 2 | Strong Buy | $50.00 | +140.85% | Maintains | 10 months ago |
X4 Pharmaceuticals IncXFOR | 1 | Strong Buy | $10.00 | +197.62% | Maintains | a year ago |
Soleno Therapeutics IncSLNO | 2 | Strong Buy | $108.00 | N/A | Maintains | 2 years ago |
Edgewise Therapeutics IncEWTX | 1 | Hold | $30.00 | N/A | Initiates Coverage On | 2 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.